MEI Pharma, Inc. Share Price Deutsche Boerse AG
Equities
MMI0
US55279B3015
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.2 EUR | -17.32% | -.--% | -.--% |
Sales 2024 * | 65.3M 60.21M 5.42B | Sales 2025 * | 6.25M 5.76M 519M | Capitalization | 20.65M 19.05M 1.72B |
---|---|---|---|---|---|
Net income 2024 * | 26M 23.97M 2.16B | Net income 2025 * | -40M -36.88M -3.32B | EV / Sales 2024 * | 0.32 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 3.3 x |
P/E ratio 2024 * |
0.86
x | P/E ratio 2025 * |
-0.54
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.3% |
Latest transcript on MEI Pharma, Inc.
1 day | -17.32% |
Managers | Title | Age | Since |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 07/14/07 |
Justin File
DFI | Director of Finance/CFO | 53 | 12/23/12 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 74 | 26/18/26 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 11/13/11 |
Charles Baltic
CHM | Chairman | 63 | 20/11/20 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- MEIP Stock
- MMI0 Stock